夏威夷見！hjc黄金城邀您相聚DMPK領域盛會ISSX 2024

hjc黄金城展位#104

藥物代謝與藥代動力學（DMPK）主要研究藥物的吸收、分布、代謝和排泄的動態過程與規律，評估藥物的 DMPK特征對藥物的前期開發和後期臨床精準用藥至關重要。DMPK是橋接藥理學、毒理學、藥劑學、藥物化學、乃至轉化醫學和精準醫學的重要橋梁。

第26屆國際藥物及化學異物代謝學會北美會議(ISSX)將於2024年9月15日至18日在美國夏威夷召開，會議內容涵蓋藥物代謝、藥代動力學、臨床藥理學、生物分析和藥物毒理學等領域。國際藥物及化學異物代謝學會(International Society for the Study of Xenobiotics，ISSX)是藥物代謝研究的最高學術組織之一，主要致力於全球範圍內從事藥物與化學異物代謝方麵的學術交流和國際合作。hjc黄金城受邀參加本次年會，hjc黄金城創始人&CEO陳春麟博士與hjc黄金城DMPK專家們期待與您相聚在104號展位。

時間 | 9.15-9.18
地點 | Hilton Hawaiian Village Waikiki Beach Resort, Honolulu
hjc黄金城展位  | 104，不見不散！

為了展示hjc黄金城創新實力和技術服務平台最新進展，hjc黄金城藥代動力學/毒代動力學 (DMPK/TK) 負責人蔣品博士將以海報 (Poster) 形式分享以下主題的精彩內容：
Title: Enhancing Drug - Drug Interaction Prediction by Integrating Physiologically- Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4
Session Time: Wednesday, September 18, 2024 12:30‒2:30 PM
Location: Poster Session 3
Poster Number: P270
Presenting : Dr. Pin Jiang, Senior Director of DMPK at Medicilon

ISSX現場hjc黄金城專家

Dr. Pin Jiang Senior Director of DMPK

Dr. Pin Jiang holds a Ph.D. from China Pharmaceutical University in collaboration with School of Pharmacy, Fudan University. Dr. Jiang is postdoctoral fellow in DMPK and Pharmacometrics at Fudan University, specializes in the development of DMPK/TK for innovative drugs. He has also published papers in international  journals such as DMD, EODMT, JSS and JPBA.

Having worked in the pharmaceutical R&D field for nearly 10years. Before joining Medicilon, Dr. Jiang held positions in the DMPK/TK and clinical pharmacology departments of well-known Biotech/Pharma/CRO companies (AstraZeneca Dizal Pharma, Covance, ChemPartner), focusing on small and large molecules. Dr. Jiang has been responsible for or involved in supporting hundreds of DMPK projects, including drugs, which have been approved by the Chinese NMPA and the US FDA for clinical research or market entry. 

Dr. Jiang also holds significant professional affiliations, serving as a youth committee member of the Drug Metabolism Committee of the Chinese Pharmacological Society (CSSX), a committee member of the Drug Metabolism Committee of the Shanghai Pharmacological Society, a youth committee member of the Pharmacology Committee of the Shanghai Pharmaceutical Association, and a member of the International Society for the Study of Xenobiotics (ISSX).

Business Communication
預約商務洽談

Dr. Peggy Teng, Executive Director BD Operations

Dr. Karsten Holm, Director of Business Development

Dr. Mingzhu Zhang, VP of Business Development